Granted Patent
B2
US 8,563,585 · App. 12/921,049 · Granted Oct 22, 2013
Fullerene therapies for inflammation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Described herein are methods for treating inflammatory disorders. The methods comprise administering to a subject in need thereof a therapeutically effective amount of a synthetically modified fullerene.
Claims (3)
1. A compound selected from the group consisting of C 70 -tetraglycolic acid, C 70 -tetrainositol, C 70 -TEG acid, and phenylpropionic acid-triazole-mixed malonateamide-C 70 -TEG-COOH.
2. A method for treating an inflammatory disease, comprising administering to a subject in need thereof a therapeutically effective amount of a compound according to claim 1 .
3. A composition comprising a compound according to claim 1 .
Assignments (5)
RELEASE OF SECURITY INTEREST
Recorded Mar 25, 2022
From: PNC BANK, NATIONAL ASSOCIATION
To: LUNA LABS USA, LLC
Reel/Frame 059396/0791 →
SECURITY INTEREST
Recorded Mar 9, 2022
From: LUNA LABS USA, LLC
To: M&T BANK
Reel/Frame 059211/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 26, 2022
From: LUNA INNOVATIONS INCORPORATED
To: LUNA LABS USA, LLC
Reel/Frame 059109/0181 →
SECURITY INTEREST
Recorded Mar 4, 2021
From: LUNA INNOVATIONS INCORPORATED; FORMER LUNA SUBSIDIARY, INC.; GENERAL PHOTONICS CORP.
To: PNC BANK, NATIONAL ASSOCIATION
Reel/Frame 056455/0331 →
RELEASE OF SECURITY INTEREST
Recorded Feb 6, 2015
From: HANSEN MEDICAL, INC.
To: LUNA INNOVATIONS INCORPORATED
Reel/Frame 034914/0407 →